Increased cancer in military pilots and ground crew: Pentagon
But military aircrew and ground crew were less likely to die from cancer, compared with the U.S. population.
Digital rectal exam fails as screening tool for prostate cancer
In a new study, 99% of digital rectal examinations did not raise suspicion for prostate cancer.
Urine test predicts future bladder cancer 12 years before symptoms
The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
Prostate cancer subgroup may benefit from intensified therapy
A new trial explored whether for patients with prostate cancer who have unfavorable features and a detectable PSA following a radical...
Talazoparib add-on improves outcomes in metastatic prostate cancer
As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide monotherapy.
Adjuvant nivolumab as standard of care in resected bladder cancer
Compared with placebo, nivolumab improves disease-free survival, nonurothelial tract recurrence-free survival, and distant metastasis-free...
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
Key factors predict gallbladder cancer on routine cholecystectomy
Identifying predictors allows surgeons to send high-risk individuals for oncologic evaluation beforehand and to prepare for intraoperative frozen...
Local therapies show promise for metastatic lung cancer
Local therapy for colorectal cancer with limited liver-only metastases is now established as a path to potentially excellent long-term survival....
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.